Further studies unraveled that STC2, like Nrf2, functions as a dominant tumor-promoter, because STC2-leading increases in clonogenicity of hepatoma cells and malgrowth of relevant xenograft tumors were almost completely abolished in STC2-/- cells 414. The gene discussed is STC2; the disease is hepatocellular carcinoma.